Literature DB >> 1989266

Bone disease in liver transplant recipients: incidence, timing, and risk factors.

M K Porayko1, R H Wiesner, J E Hay, R A Krom, E R Dickson, S Beaver, L Schwerman.   

Abstract

Mesh：

Year:  1991        PMID： 1989266

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  20 in total

Review 1.  Osteoporosis in chronic liver disease.

Authors:  J Heathcote
Journal:  Curr Gastroenterol Rep       Date:  1999-12

Review 2.  The management of primary sclerosing cholangitis.

Authors:  Roger W Chapman
Journal:  Curr Gastroenterol Rep       Date:  2003-02

3.  Sirolimus therapy in orthotopic liver transplant (OLT) recipients with acute renal insufficiency.

Authors:  Marzia Montalbano; Guy W Neff; Grabriella Slapak-Green; Thierry Berney; Douglas Meyer
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

4.  Rapid multifocal chondrolysis after liver transplantation in four patients.

Authors:  J Taillandier; M Alemanni; D Samuel; H Bismuth; F Lioté
Journal:  Ann Rheum Dis       Date:  2006-01       Impact factor: 19.103

5.  Bone disease after liver transplantation should not be underestimated.

Authors:  J E Compston; G A Alexander
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

6.  Bone loss after liver transplantation is not prevented by cyclical etidronate, calcium and alphacalcidol. The Liver Transplant Group, Groningen.

Authors:  S C Riemens; A Oostdijk; J J van Doormaal; C J Thijn; G Drent; D A Piers; E W Groen; L Meerman; M J Slooff; E B Haagsma
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

Review 7.  Metabolic bone disease in patients with liver disease.

Authors:  Elizabeth Carey; Vijayan Balan
Journal:  Curr Gastroenterol Rep       Date:  2003-02

Review 8.  Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 1?

Authors:  P Cochat; K Schärer
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

9.  Bone mineral density and body composition in adult patients with cystic fibrosis.

Authors:  A B Grey; R W Ames; R D Matthews; I R Reid
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

10.  Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in rats.

Authors:  I Joffe; I Katz; S Sehgal; F Bex; Y Kharode; J Tamasi; S Epstein
Journal:  Calcif Tissue Int       Date:  1993-07       Impact factor: 4.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.